Ingevity Corp Net Asset
| NGVT Stock | USD 74.07 -3.80 -4.88% |
| = | 1.65 B |
Ingevity Corp's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets are sold, the net asset will be the amount that the shareholders would demand back from the fund.
Net Asset | = | Current Market Value | - | Current Liabilities |
Current Ingevity Corp Net Asset | 1.65 B |
Most of Ingevity Corp's key ratios, such as Net Asset, are part of a framework for finding mispriced stocks. When core analysis points to a higher value than the market sets, it may signal a chance for more research. The size of the gap between market price and core value can show the strength of a possible chance. Ingevity Corp currently trades at a P/E of 16.90, which provides additional valuation context.
| Competition |
Fundamental Drivers Relationships
Net Asset Peer Comparison
Peer comparison of Ingevity Corp using Net Asset provides a quantitative benchmark against similar stocks. Identifying gaps in Ingevity Corp's Net Asset relative to peers supports more targeted investment analysis.Ingevity Corp is currently under evaluation in net asset relative to competitors.
Important Fundamentals
| Return On Equity TTM | -1.34 | |||
| Return On Asset TTM | 0.0891 | |||
| Profit Margin TTM | -0.14 | |||
| Operating Margin TTM | 0.15 | |||
| Current Valuation | 3.76 B | |||
| Shares Outstanding | 35.22 M | |||
| Shares Owned By Insiders | 0.77 % | |||
| Shares Owned By Institutions | 99.23 % | |||
| Number Of Shares Shorted | 1.15 M | |||
| Price To Earnings TTM | 16.90 X | |||
| Price To Book TTM | 87.51 X | |||
| Price To Sales TTM | 2.33 X | |||
| Revenue TTM | 1.17 B | |||
| Gross Profit TTM | 461.5 M | |||
| EBITDA TTM | 37.4 M | |||
| Net Income TTM | -167.1 M | |||
| Cash And Equivalents TTM | 131.3 M | |||
| Cash Per Share TTM | 3.45 X | |||
| Total Debt TTM | 1.24 B | |||
| Debt To Equity TTM | 1.88 % | |||
| Current Ratio TTM | 2.54 X | |||
| Book Value Per Share TTM | 0.84 X | |||
| Cash Flow From Operations TTM | 331.2 M | |||
| Short Ratio TTM | 3.72 X | |||
| Earnings Per Share | -4.15 X | |||
| Price To Earnings To Growth | 2.41 X | |||
| Target Price | 80.5 | |||
| Number Of Employees | 1.5 K | |||
| Trailing Beta | 1.24 | |||
| Market Capitalization TTM | 2.72 B | |||
| Total Asset TTM | 1.65 B | |||
| Retained Earnings TTM | 404.9 M | |||
| Working Capital TTM | 112.9 M | |||
| Current Asset TTM | 299.4 M | |||
| Current Liabilities TTM | 97.2 M | |||
| Net Asset | 1.65 B |
Financial Metrics, Fundamentals & Methodology
Core financial indicators for Ingevity Corp help show whether operating productivity is strengthening or weakening. Capital intensity is provided as a reference for reinvestment requirements. In recent filings, Ingevity Corp reported revenue of 1.17 billion, EPS loss of 4.15, operating margin of 15.21% as of the latest reporting period.
Ingevity Corp data is compiled from periodic company reporting and market reference feeds and standardized for comparability. Statement-level metrics reflect company-reported GAAP or IFRS formats for the relevant filing period.
Editorial review and methodology oversight provided by: Ellen Johnson, Member of Macroaxis Editorial Board